On the formation of seven-membered rings by arene-ynamide cyclization
128.6, 128.4, 125.8, 71.3, 70.3, 62.9, 47.2, 35.9, 31.1, 28.8,
28.6, 18.5 ppm; IR: ̄ꢀ =3060, 3025, 2931, 2857, 2266, 1769,
1603, 1480, 1454, 1415, 1302, 1264, 1206, 1113, 1036, 747,
701 cm−1; HRMS (ESI): m/z calculated for [M]+ 257.1416,
found 257.1412.
by column chromatography (pentane/EE = 3:1–1:1) as a
white solid (25 mg, 0.18 mmol, 89%). 1H NMR (400 MHz,
CDCl3): δ = 7.50 (dd, 1H), 6.56 (dd, J = 17.0, 1.8 Hz,
1H), 5.90 (dd, J= 10.5, 1.8 Hz, 1H), 4.44 (t, 2H), 4.09 (t,
2H) ppm; 13C NMR (100 MHz, CDCl3): δ=165.2, 153.5,
131.9, 127.1, 62.3, 42.8 ppm; IR: ̄ꢀ = 1775, 1717, 1687,
1412, 1389, 1327, 1264, 1118, 1066, 1040, 1014, 732,
702 cm−1; HRMS (ESI): m/z calculated for [M]+ 141.0426,
found 141.0417.
General procedure of cyclization of ynamide
The respective ynamide (0.20 mmol, 1.0 equiv.) was dis-
solved in dry DCM under inert atmosphere at 0 °C. Trific
acid (0.20 mmol, 1.0 equiv.) was added dropwise using a
microsyringe and stirred for 1 h. The reaction was quenched
by the addition of a sat. NH4Cl solution. The reaction mix-
ture was extracted with DCM and the combined organic
phases were dried over MgSO4 and concentrated under
reduced pressure. The residue was purifed by column chro-
matography on silica gel.
Acknowledgements Open access funding provided by Austrian Sci-
ence Fund (FWF). We are grateful to the ERC (CoG VINCAT) and
the FWF (P30226) for fnancial support. Generous continued support
of our research programs by the University of Vienna is gratefully
acknowledged.
credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
3‑(6,7‑Dihydro‑5H‑benzo[g]annulen‑9‑yl)oxazolidin‑2‑one
(2a, C14H15NO2) According to the general procedure,
69 mg 1a (0.30 mmol, 1.0 equiv.) and 45 mg trific acid
(0.30 mmol, 1.0 equiv.) were reacted in 3 cm3 DCM and
the corresponding cyclization product 2a was isolated after
purifcation by column chromatography (pentane/EE=3:1–
1:1) as a white solid (56 mg, 0.24 mmol, 81%). The ketone
side product was isolated as white solid (7 mg, 0.03 mmol,
10%). 1H NMR (400 MHz, CDCl3): δ=7.24 (m, 5H), 6.25
(t, J = 7.1 Hz, 1H), 4.39 (ddd, J = 8.1, 7.2, 2.7 Hz, 2H),
3.68 (t, 2H), 2.66 (t, J=6.8 Hz, 2H), 2.15 (p, 2H), 2.00 (p,
2H) ppm; 13C NMR (100 MHz, CDCl3): δ=129.5, 128.2,
126.6, 126.4, 124.3, 61.8, 46.7, 34.7, 32.6, 24.1 ppm; IR:
̄ꢀ =2928, 2857, 1751, 1634, 1481, 1452, 1112, 1086, 1038,
898, 773, 756, 730, 702, 607 cm−1; HRMS (ESI): m/z cal-
culated for: [M]+ 229.1103, found 229.1094.
References
1. Yet L (2003) Chem Rev 103:4283
2. Shen R, Lin CT, Bowman EJ, Bowman BJ, Porco JA (2003) J Am
Chem Soc 125:7889
3. Lin S, Yang ZQ, Kwok BHB, Koldobskiy M, Crews CM, Dan-
ishefsky SJ (2004) J Am Chem Soc 126:6347
4. Martín MJ, Coello L, Fernández R, Reyes F, Rodríguez A, Murcia
C, Garranzo M, Mateo C, Sánchez-Sancho F, Bueno S, de Eguil-
ior C, Francesch A, Munt S, Cuevas C (2013) J Am Chem Soc
135:10164
5. Tian PP, Cai SH, Liang QJ, Zhou XY, Xu YH, Loh TP (2015) Org
Lett 17:1636
6. Zhang YS, Hsung RP, Zhang XJ, Huang J, Slafer BW, Davis A
(2005) Org Lett 7:1047
3‑(3‑Methyl‑6,7‑dihydro‑5H‑benzo [7] annulen‑9‑yl)oxazoli‑
din‑2‑one (2b, C15H17NO2) According to the general proce-
dure, 2b was isolated as a white solid (109 mg, 0.446 mmol,
90%). The ketone side product 8 was isolated as a colorless
oil (0.8 mg, 0.005 mmol, 1%). 1H NMR (600 MHz, CDCl3):
δ=7.14–7.00 (m, 4H), 6.23 (t, J =7.2 Hz, 1H), 4.41–4.38
(m, 2H), 3.70–3.65 (m, 2H), 2), 2.61 (t, J = 6.9 Hz, 2H),
2.33 (s, 3H), 2.11 (p, J=7.2 Hz, 2H), 1.98 (q, J=7.2 Hz,
2H) ppm; 13C NMR (151 MHz, CDCl3): δ=156.9, 139.3,
135.8, 135.4, 134.8, 130.7, 129.4, 129.0, 127.0, 124.4 ppm;
IR: ̄ꢀ = 2923, 2855, 1743, 1632, 1480, 1447, 1397, 1364,
1287, 1258, 1221, 1147, 1119, 1083, 1066, 1036, 976, 923,
825, 794, 757, 732, 683 cm−1; HRMS (ESI): m/z calculated
for [M+H]+ 244.1338, found 244.1335.
7. DeKorver KA, Li H, Lohse AG, Hayashi R, Lu Z, Zhang Y, Hsung
RP (2010) Chem Rev 110:5064
8. Evano G, Blanchard N, Compain G, Coste A, Demmer CS, Gati
W, Guissart C, Heimburger J, Henry N, Jouvin K, Karthikeyan G,
Laouiti A, Lecomte M, Martin-Mingot A, Métayer B, Michelet B,
Nitelet A, Theunissen C, Thibaudeau S, Wang J, Zarca M, Zhang
C (2016) Chem Lett 45:574
9. Evano G, Theunissen C, Lecomte M (2015) Aldrichim Acta 48:59
10. Evano G, Jouvin K, Coste A (2013) Synthesis 45:17
11. Peng B, Huang XL, Xie LG, Maulide N (2014) Angew Chem Int
Ed 53:8718
12. Xie LG, Niyomchon S, Mota AJ, Gonzalez L, Maulide N (2016)
Nat Comm 7:10914
13. Kaldre D, Klose I, Maulide N (2018) Science 361:664
14. Maryasin B, Kaldre D, Galaverna R, Klose I, Ruider S, Drescher
M, Kählig H, González L, Eberlin M, Jurberg I, Maulide N (2018)
Chem Sci 9:4124
15. Pinto A, Kaiser D, Maryasin B, Di Mauro G, González L, Maulide
N (2018) Chem Eur J 24:2515
3‑Acryloyloxazolidin‑2‑one (2e, C6H7NO3) According to
the general procedure, 46 mg 1e (0.2 mmol, 1.0 equiv.) and
30 mg trific acid (0.2 mmol, 1.0 equiv.) were reacted in
2 cm3 DCM and the amide 2e was isolated after purifcation
16. Kaldre D, Maryasin B, Kaiser D, Gajsek O, González L, Maulide
N (2017) Angew Chem Int Ed 56:2212
1 3